¦p¦ó¿ï¾ÜÆ^´O«¬FL¶i¦æFL´Ó¤J? 2018-09-14
|
|
|
FLµÛ§É«e°ò¦]ÀË´ú (Preimplantation genetic testing for aneuploidy, PGT-A)ªº§Þ³N¶V¨Ó¶V¶i¨B¡A¸ÑªR«×¤]¶V°ª¡A¥Ø«e¥H¦¸¥@¥N©w§Ç(Next generation sequencing¡ANGS)¤è¦¡¬°¥D¬y¡A§@ªk¬O·í ...¥þ¤å¾\Ū |
|
°ª«~½è¾ã¿ÅéÅnFªº¦¬ÁY¦æ¬°·|°§CFLªºµÛ§É¤O 2018-09-14
|
|
|
FL§Y®ÉºÊ±±¨t²Î(Time-lapse monitoring; TLM)ªºµo®iÅýFLªº¬D¿ï°£¤F®Ú¾Ú¶Ç²Îªº¥~Æ[«¬ºA¤§¥~ÁÙ¥i¥H®Ú¾ÚFLµo¨|ªº°ÊºAÅܤƬD¿ï¦nªºFL°µ´Ó¤J¡Cªñ´X¦~µo®iªº°ò¦]ÀË´ú§Þ³N¤]Åý§ÚÌ¥i¥HÂǥѿz¿ï¥¿±`¬V¦âÅ骺ÅnF°µ´Ó¤J¥H´£°ªÅnFµÛ ...¥þ¤å¾\Ū |
|
Ãö©ó¤H¤u¥Í´Þ©Ò²£¥Íªº¦hML¦b¥ý¤Ñ©Ê²§±`ªº·ÀI 2018-09-04
|
|
|
¨ì¥Ø«e¬°¤î¡A¤H¤u¥Í´Þ§Þ³N¬°¥@¬É±a¨Ó¤F¶W¹L¤¦Ê¸UÓ·s¥Í©R¡A¬Æ¦Ü©ó¬Y¨Ç°ê®a¤¤¡A¸ÕºÞÀ¦¨à¦û¥X¥ÍÁ`¤H¤f¼Æªº1.5%〜6.0%¡A¨ä¤¤¤@Ó³y¦¨¸ÕºÞÀ¦¨à¥X¥Í¤H¤f¼Æ¤É°ªªºì¦]´N¬O¦hML¡A¤H¤u¥Í´Þ§Þ³N¬°¤F°l¨D¸û°ªªºÃh¥¥²v¡A³q±`·|´Ó¤J¤j ...¥þ¤å¾\Ū |
|
¤HÃþºë¤l§À³¡¦³¥O¤HÅå©_ªº·sµo²{ 2018-08-26
|
|
|
¤HÃþªººë¤l¹ï¤@Ó¦¨¼ô¨k©Êªº¥Í´Þ²ÓM¦Ó¨¥¡A·L¦åºÞ¬O¦³©Ê¥Í´Þ¦¨¥\»P§_ªºÃöÁä©Ò¦b¡Cºë¤l¬Ý°_¨Ó´N¹³¬O¤@°¦¤p¤pªº¥b³z©ú½Á°B¡A¥¦¦³ÓÀY³¡¡B¤¤¬q¡AÁÙ¦³±øÂ\°Êªº§À³¡¡A¨ó§U¥¦´å¦V§Z¤l±Âºë¡C¤@¦ì¨k©Ê¨C¬í¥i¥H²£¥Í1500Óºë¤l¡A¦Ó¤@¦¸®gºë¥] ...¥þ¤å¾\Ū |
|
ºë¤l©ñ¦b¤ÓªÅ¤¤·|Ãa±¼¶Ü¡H 2018-08-26
|
|
|
¾Ú¬ã¨s¤Hû³ø¾É¡A¦b§â§Ná°®Àꪺ¤p¹«ºë¤l°e¤W¦a²yy¹D¡B¼ÉÅS¦bÄY®mªº¤ÓªÅÀô¹Ò¤j¬ù¤EÓ¤ë«á¡A¨ÌµM¯à²£¥Í°·±dªº¤p¹«¡C
¹ïÂå¾Ç±M®a¨Ó»¡¡A³o¶µµ²ªG¨Ã¤£·N¥~¡F¦ý¬O¡A°²¦p¥¼¨Óªº¤HÃþ·Qn²¾¥Á¨ì¦a²y¥H¥~ªº¦a¤è¡A»Ýn³z¹L»²§U¥Í ...¥þ¤å¾\Ū |
|
|